Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.52 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.45 |
| ▸ | FDPS | P14324 | 8/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL3264802 | 1.00 | CES2 (0.52) | CES2GGPS1FDPSEPHX1CES1 | |
| SCHEMBL28626290 | 0.95 | CES2 (0.52) | CES2GGPS1FDPSEPHX1CES1 | |
| SCHEMBL8595299 | 0.95 | CES2 (0.56) | CES2GGPS1FDPSEPHX1CES1 | |
| SCHEMBL6682242 | 0.95 | CES2 (0.56) | CES2GGPS1FDPSEPHX1CES1 | |
| Acetone SCHEMBL10601124 | 0.86 | CES2 (0.47) | CES2GGPS1FDPSEPHX1CES1 | |
| Acetone SCHEMBL5983365 | 0.86 | CES2 (0.47) | CES2GGPS1FDPSEPHX1CES1 | |
| SCHEMBL4361811 | 0.83 | CES2 (0.48) | CES2GGPS1FDPSEPHX1CES1 | |
| SCHEMBL7105885 | 0.83 | CES2 (0.48) | CES2GGPS1FDPSEPHX1CES1 | |
| SCHEMBL5027714 | 0.82 | CES2 (0.44) | CES2GGPS1FDPSEPHX1 | |
| Acetone SCHEMBL3269116 | 0.80 | FAAH (0.55) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1122668-C | Epothilone derivatives and their use as antitumor agents | NOVARTIS AG (CH) | 2003-10-01 | — | — | CN | disclosed |
| EP-1140944-B1 | EPOTHILONE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS | NOVARTIS AG (CH) | 2003-08-27 | — | — | EP | disclosed |
| US-6387927-B1 | WATER SOLUBILITY | NOVATIS AG (CH) | 2002-05-14 | — | — | US | disclosed |
| CN-1332742-A | Epothilone derivatives and their use as antitumor agents | NOVARTIS AG (CH) | 2002-01-23 | — | — | CN | disclosed |
| EP-1140944-A1 | EPOTHILONE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS | Novartis AG (CH) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000037473-A1 | EPOTHILONE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS | NOVARTIS AG (CH) | 2000-06-29 | — | — | WO | disclosed |